Promoting Excellence in Education, Research,
and Patient Care in the Rapidly Evolving
Management of Gastrointestinal Cancer
International Society of
Gastrointestinal Oncology
isgioEstablished 2003
Save the Date for the ISGIO 2017 Conference
The 2018 Gastrointestinal Oncology Conference
The 2018 Gastrointestinal Oncology Conference, the official meeting of the International Society of Gastrointestinal Oncology, will take place November 1-2, 2018 at the Hilton Crystal City in Arlington, VA and will provide an educational forum for presenting and discussing the latest advances in the broad field of GI cancer research, as well as critical issues relevant to the care of persons with GI cancer.

Registration is now open!
Agenda
Thursday, November 1, 2018
8:05AM – 8:10AM Introduction and Welcome From The President
Howard Hochster, MD
Session 1: Pancreatic Cancer
Chairpersons: Michael Choti, MD; Eileen O'Reilly, MD
8:10AM – 8:25AM Screening of Patients at Risk for Familial Pancreatic Cancer: Who To Screen, How To Screen, When to Screen?
8:25AM – 8:30AM Q & A (5 minutes)
8:30AM – 8:45AM Personalized Therapies in Pancreatic Ductal Adenocarcinoma: Are We There Yet?
8:45AM – 8:50AM Q & A (5 minutes)
  Debate: Role for Local/Regional Therapy in Advanced Disease
8:50AM – 9:05AM Pro: TBD
9:05AM – 9:15AM Con: TBD
9:15AM – 9:30AM Panel Discussion
Moderators: Michael Choti, MD; Eileen O’Reilly, MD
9:30AM – 9:40AM Case 1: Borderline PDAC with Arterial Abutment
9:40AM – 9:50AM Case 2: Recurrence of Adenocarcinoma in the Remnant Pancreas (Following IPMN-associated PDAC)
9:50AM – 10:00AM Case 3: Case of Advanced PDAC, Progression Beyond First Line and Carcinomatosis
10:00AM – 10:15AM Panel Discussion
Moderators: Michael Choti, MD; Eileen O’Reilly, MD
10:15AM – 10:35AM Break/Posters Available for Viewing
Session 2: Hepatobiliary Cancer
Chairpersons: Michael Choti, MD; Ghassan Abou-Alfa, MD
10:35AM – 10:50AM Managing Incidental Gallbladder Cancer
10:50AM – 10:55AM Q & A (5 minutes)
10:55AM – 11:10AM Systemic Therapy Sequencing for Advanced HCC: Navigating the Changing Landscape
11:10AM – 11:15AM Q & A (5 minutes)
  Debate: Adjuvant Therapy for Cholangiocarcinoma
11:15AM – 11:25AM Chemoradiation is Best
11:25AM – 11:35AM Chemotherapy Alone is the Way to Go
11:35AM – 11:50PM Panel Discussion
Moderators: Michael Choti, MD; Ghassan Abou-Alfa, MD
11:50PM – 12:00PM Case 1: Intrahepatic Recurrence Following Resection of HCC
12:00PM – 12:10PM Case 2: Fibrolamellar Carcinoma
12:10PM – 12:20PM Case 3: Multidisciplinary Management of Distal Cholangiocarcinoma
12:25PM – 12:35PM Panel Discussion
Moderators: Michael Choti, MD; Ghassan Abou-Alfa, MD
12:35PM – 2:00PM Lunch Break / Satellite Symposia
Session 3: Esophageal/Gastric Cancer
Chairpersons: David Ilson, MD, PhD
  Debate:
2:00PM – 2:10PM Preoperative Therapy with FLOT is the Preferred Treatment for Esophageal and GEJ Adenocarcinoma
2:10PM – 2:20PM Preoperative Chemotherapy and Radiation Therapy is the Preferred Treatment
2:20PM – 2:35PM Panel Discussion
Moderator: David Ilson, MD
2:35PM – 2:50PM Current Status and Future Directions of Targeted Agents and Immunotherapy in Gastric Cancer
2:50PM – 2:55PM Q & A (5 minutes)
2:55PM – 3:10PM Genomic Profiling and Biomarker Guided Therapy in Esophagogastric Cancer
3:10PM – 3:15PM Q & A (5 minutes
3:15PM – 3:25PM Case 1: Observation Versus Immediate Surgery for Clinical Complete Response to Chemort in Esophageal Cancer
3:25PM – 3:35PM Case 2: Earlier versus Later use of Immunotherapy Agents in Met Gastric Cancer that is either MSI High or PDL1 Positive
3:35PM – 3:50PM Panel Discussion
3:50PM Meeting Adjourns
   
Friday, November 2, 2018
Session 4: Hot Topics in Gastrointestinal Oncology
Chairpersons: Axel Grothey, MD, Howard Hochster, MD
8:00AM – 8:15AM Immuno-oncology - Beyond PD1 Single Agent
8:15AM – 8:20AM Q & A (5 minutes)
8:20AM – 8:35AM Cellular Therapies - Wishful Thinking in GI Cancer?
8:35AM – 8:40AM Q & A (5 minutes)
  Debate - Tumor Mutation Profiling in GI Cancer - Worthwhile or Not?
8:40AM – 8:50AM Pro -
8:50AM – 9:00AM Con -
9:00AM – 9:15AM Panel Discussion
Moderator: Axel Grothey, MD; Howard Hochster, MD
9:15AM – 9:30AM ESMO Update
9:30AM – 9:35AM Q & A (5 minutes)
Session 5: Localized/Adjuvant Colorectal Cancer
Chairpersons: Daniel Haller, MD
9:35AM – 9:50AM Duration of Adjuvant Therapy for Colon Cancer
9:50AM – 9:55AM Q & A (5 minutes)
  Debate: Non-Operative Management of Rectal Cancer
9:55AM – 10:05AM Pro -
10:05AM – 10:15AM CON -
10:15AM – 10:30AM Panel Discussion
Moderator: Daniel Haller, MD
10:30AM – 10:40AM Case 1: Rectal Cancer with Synchronous Metastasis
10:40AM – 10:55AM Panel Discussion
Moderator: Daniel Haller, MD
10:55AM – 11:15AM Break/Posters Available for Viewing
Session 6: Neuroendocrine Tumors (NET)
Chairperson: Jonathan Strosberg, MD
11:15AM – 11:30AM Endoscopic and Surgical Management of Gastric and Duodenal NETs
11:30AM – 11:35AM Q & A (5 minutes)
  Debate: Radioembolization for Liver Metastases
11:35AM – 11:45AM Pro -
11:45AM – 11:55AM Con -
11:55AM – 12:15PM Panel Discussion
Moderator: Jonathan Strosberg, MD
12:15PM – 12:30PM High Grade Neuroendocrine Cancers: Should They all be Treated Similarly?
12:30PM – 12:35PM Q & A (5 minutes)
12:35PM – 12:50PM 177Lu-DOTATATE: Patient Selection and Practical Treatment Considerations
12:50PM – 12:55PM Q & A (5 Minutes)
12:55PM – 1:10PM Case 1: Discussion of Treatment Options for NET Progressing on First-line Somatostatin Analog
1:10PM – 1:25PM Panel Discussion
Moderator: Jonathan Strosberg, MD
1:25PM – 2:55PM Lunch Break / Satellite Symposia
Session 7: Advanced Colon Cancer
Chairpersons: Axel Grothey, MD; Al Benson, MD
2:55PM – 3:05PM How I Treat mCRC? Making Sense of all the Dat
3:05AM – 3:10PM Q & A (5 minutes)
3:10PM – 3:25PM BRAF Mutated mCRC – Specific Considerations for Treatment
3:25PM – 3:30PM Q & A (5 minutes)
3:30PM – 3:45PM Potentially Curable Metastatic Rectal Cancer: Best Approaches
3:45PM – 3:50PM Q & A (5 minutes)
3:50PM – 4:00PM Case 1: HER2 Over Expression to Highlight the S1613 Trial
4:00PM – 4:10PM Case 2: ctDNA Guiding Treatment
4:10PM – 4:20PM Panel Discussion
Moderator: Axel Grothey, MD; Al B. Benson III, MD
4:20PM Meeting Adjourns